WAT's Quality Score fell 3 points on Fri, Oct 30, to 13. Closed away from the day's high (2 chart checks stopped). 1 more reason, for Pro members.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Up 35% in a year while the S&P 500 rose 12%.
“Instrument system sales increased 5% in 2025 as compared to 2024 reflecting broad-based customer demand across most global regions.”
| The chart | Stronger than 87% of stocks |
| Its score | Up:Above Average or better for 94 days in a row |
| Latest filing | 10-Q, Aug 11 |
TodayWith its group.
After its last 4 reports it closed +2.9% on average, higher 3 of 4 times.
Above Averagefor quality, not price, 5 of 14 chart checks firingWhat the Quality Score means
WAT is #3 of 15 by Quality Score among Laboratory Analytical Instruments.
| 1 | ||
| 2 | ||
| 3 | ||
| Open for its score | ||
| Open for its score | ||
| Open for its score |
Share count against a year before: WAT +65%, RVTY -5%, ILMN -3.8%, MTD -2.7%.
Reports Tue Nov 3, before the open (tomorrow). Confirmed.
What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.
The figures are not read from the release yet.
WAT's results filing gives no sales by line in a table we read.
| Measure | Figure |
|---|---|
| Acquired business reported revenue | about $3.045B |
Sales grew 6% a year over 5 years, fiscal 2020 to 2025.
Its share count fell 0.9% a year over 5 years.
| Reported | Gap | Reaction | 5 sessions |
|---|---|---|---|
| Aug 4, 2026 | +2.3% | +5.7% | +9.9% |
| May 5, 2026 | +12.0% | +13.5% | +15.3% |
| Feb 9, 2026 | -12.8% | -13.9% | -15.2% |
Sales grew in four of the last seven years, to $3.2B in 2025. It made a profit in each of the four years.
One insider sold $1.4M across 1 filing in the last 6 months. No open-market buys on record. The newest:
7 trades disclosed in the last six months. The newest:
Officers and directors with a Form 4 in the last 12 months.
In ETFs: WAT is 0.2% of SCHG, under 0.1% of VOO, and under 0.1% of IVV, the most of the 24 funds Breakaway covers, by each fund's latest filing, Jun 30 to Aug 31, 2026.
Waters sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. In early 2026, Waters merged with Becton Dickinson's life science and diagnostics business, which increased its concentration in diagnostics and discovery-related life science tools.
“The analytical instrument systems, supplies and services market is highly competitive.”
WAT scores 13 today, which Breakaway calls Above Average. It is #3 of 15 in Laboratory Analytical Instruments by Quality Score, with 5 of 14 chart checks firing. Up 35% in a year while the S&P 500 rose 12%. Shares: 65.0% more than a year ago (to Jul 4). Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.
WAT scores 13 today, which Breakaway calls Above Average (11 to 14). That is #3 of 15 in Laboratory Analytical Instruments by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind WAT's 13.
One insider sold $1.4M across 1 filing in the last 6 months. No open-market buys on record. The newest is Christopher A. Kuebler, Director, who sold $1.4M on Aug 6.
Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.